Stribild Tablet, Film Coated
Product Images NDC 61958-1201

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Stribild (NDC 61958-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Stribild 01)

FDA Label Image

Chemical Structure (Stribild 02)

FDA Label Image

Chemical Structure (Stribild 03)

FDA Label Image

Chemical Structure (Stribild 04)

FDA Label Image

Chemical Structure (Stribild 05)

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

FDA Label Image

Stribild 07

Stribild tablets are a combination of several active ingredients including 150mg of elvitegravir, 200mg of emtricitabine, and 300mg of tenofovir disoproxil. They are available in a package containing 30 tablets and are designed to be used in the treatment of certain types of viruses. The pack contains an ALERT box, and the pharmacist is advised not to cover it with the pharmacy label. The medication is manufactured by Gilead Sciences in Canada and should be kept in its original container. Dosage instructions are also provided, and caution is given to keep it out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.